N-oxygenation of clozapine by flavin-containing monooxygenase.

The involvement of FMO in the N-oxygenation of CLZ was investigated by use of purified FMOs and human liver microsomes that contained the mean amount of immunoreactive FMO3 relative to other human liver microsomal preparations in a liver bank. In the microsomal preparation the involvement of FMO was indicated through enzyme inhibition by methimazole, heat inactivation, and protection against heat inactivation by NADPH. Also the Michaelis-Menten kinetic constant; KM determined for CLZ N-oxidation catalyzed by purified human FMO3 (324 microM) was very similar to the mean value obtained in these laboratories for the microsomal preparations of seven human livers.

[1]  K. Itagaki,et al.  Expression and Characterization of a Modified Flavin-containing Monooxygenase 4 from Humans* , 1996, The Journal of Biological Chemistry.

[2]  K. Midha,et al.  Characterization of metabolites of clozapine N-oxide in the rat by micro-column high performance liquid chromatography/mass spectrometry with electrospray interface. , 1996, Journal of pharmaceutical and biomedical analysis.

[3]  M. Byerly,et al.  Pharmacokinetics of clozapine and risperidone: a review of recent literature. , 1996, Journal of clinical psychopharmacology.

[4]  S. Binkley,et al.  In vitro interaction of the antipsychotic agent olanzapine with human cytochromes P450 CYP2C9, CYP2C19, CYP2D6 and CYP3A. , 1996, British journal of clinical pharmacology.

[5]  I. Phillips,et al.  Differential developmental and tissue-specific regulation of expression of the genes encoding three members of the flavin-containing monooxygenase family of man, FMO1, FMO3 and FM04. , 1996, European journal of biochemistry.

[6]  K. Midha,et al.  Application of electrospray mass spectrometry in the identification of intact glucuronide and suplate conjugates of clozapine in rat. , 1996, Xenobiotica; the fate of foreign compounds in biological systems.

[7]  J R Cashman,et al.  Structural and catalytic properties of the mammalian flavin-containing monooxygenase. , 1995, Chemical research in toxicology.

[8]  Dominic P. Williams,et al.  Metabolism and bioactivation of clozapine by human liver in vitro. , 1995, The Journal of pharmacology and experimental therapeutics.

[9]  K. Midha,et al.  Identification of clozapine N(+)-glucuronide in the urine of patients treated with clozapine using electrospray mass spectrometry. , 1994, Biological mass spectrometry.

[10]  J. Cashman,et al.  A nomenclature for the mammalian flavin-containing monooxygenase gene family based on amino acid sequence identities. , 1994, Archives of biochemistry and biophysics.

[11]  A. Rettie,et al.  Stereoselective sulfoxidation by human flavin-containing monooxygenase. Evidence for catalytic diversity between hepatic, renal, and fetal forms. , 1992, Drug metabolism and disposition: the biological fate of chemicals.

[12]  V. Fischer,et al.  The antipsychotic clozapine is metabolized by the polymorphic human microsomal and recombinant cytochrome P450 2D6. , 1992, The Journal of pharmacology and experimental therapeutics.

[13]  R. Baldessarini,et al.  Clozapine. A novel antipsychotic agent. , 1991, The New England journal of medicine.

[14]  L. Friedman,et al.  Clozapine--a novel antipsychotic agent. , 1991, The New England journal of medicine.

[15]  A. Rettie,et al.  Stereoselective sulfoxidation of a series of alkyl p-tolyl sulfides by microsomal and purified flavin-containing monooxygenases. , 1990, Molecular pharmacology.

[16]  J. Proudfoot,et al.  Stereoselective N-oxygenation of zimeldine and homozimeldine by the flavin-containing monooxygenase. , 1988, Drug metabolism and disposition: the biological fate of chemicals.

[17]  D. Ziegler,et al.  Flavin-containing monooxygenases: catalytic mechanism and substrate specificities. , 1988, Drug metabolism reviews.

[18]  G. L. Kedderis,et al.  Loss of rat liver microsomal cytochrome P-450 during methimazole metabolism. Role of flavin-containing monooxygenase. , 1985, Drug metabolism and disposition: the biological fate of chemicals.

[19]  S. Sofer,et al.  Microsomal mixed-function amine oxidase. Oxidation products of piperazine-substituted phenothiazine drugs. , 1978, Drug metabolism and disposition: the biological fate of chemicals.

[20]  L. Poulsen,et al.  [14] Hepatic microsomal mixed-function amine oxidase , 1978 .

[21]  E. Faeder,et al.  A rapid micromethod for determination of FMN and FAD in mixtures. , 1973, Analytical biochemistry.

[22]  R. Estabrook,et al.  The Spectrophotometric Measurement of Turbid Suspensions of Cytochromes Associated with Drug Metabolism , 1972 .

[23]  D. Ziegler,et al.  Oxidative metabolism of tertiary amine drugs by human liver tissue. , 1971, Xenobiotica; the fate of foreign compounds in biological systems.